0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Mitochondrial dynamics and metabolic regulation control T cell fate in the thymus

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Several studies demonstrated that mitochondrial dynamics and metabolic pathways control T cell fate in the periphery. However, little is known about their implication in thymocyte development. Our results showed that thymic progenitors (CD3 -CD4 -CD8 - triple negative, TN), in active division, have essentially a fused mitochondrial morphology and rely on high glycolysis and mitochondrial oxidative phosphorylation (OXPHOS). As TN cells differentiate to double positive (DP, CD4 +CD8 +) and single positive (SP, CD4 + and CD8 +) stages, they became more quiescent, their mitochondria fragment and they downregulate glycolysis and OXPHOS. Accordingly, in vitro inhibition of the mitochondrial fission during progenitor differentiation on OP9-DL4 stroma, affected the TN to DP thymocyte transition by enhancing the percentage of TN and reducing that of DP, leading to a decrease in the total number of thymic cells including SP T cells. We demonstrated that the stage 3 triple negative pre-T (TN3) and the stage 4 triple negative pre-T (TN4) have different metabolic and functional behaviors. While their mitochondrial morphologies are both essentially fused, the LC-MS based analysis of their metabolome showed that they are distinct: TN3 rely more on OXPHOS whereas TN4 are more glycolytic. In line with this, TN4 display an increased Hexokinase II expression in comparison to TN3, associated with high proliferation and glycolysis. The in vivo inhibition of glycolysis using 2-deoxyglucose (2-DG) and the absence of IL-7 signaling, led to a decline in glucose metabolism and mitochondrial membrane potential. In addition, the glucose/IL-7R connection affects the TN3 to TN4 transition (also called β-selection transition), by enhancing the percentage of TN3, leading to a decrease in the total number of thymocytes. Thus, we identified additional components, essential during β-selection transition and playing a major role in thymic development.

          Related collections

          Most cited references66

          • Record: found
          • Abstract: found
          • Article: not found

          A guide to immunometabolism for immunologists.

          In recent years a substantial number of findings have been made in the area of immunometabolism, by which we mean the changes in intracellular metabolic pathways in immune cells that alter their function. Here, we provide a brief refresher course on six of the major metabolic pathways involved (specifically, glycolysis, the tricarboxylic acid (TCA) cycle, the pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis and amino acid metabolism), giving specific examples of how precise changes in the metabolites of these pathways shape the immune cell response. What is emerging is a complex interplay between metabolic reprogramming and immunity, which is providing an extra dimension to our understanding of the immune system in health and disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Fueling immunity: insights into metabolism and lymphocyte function.

            Lymphocytes face major metabolic challenges upon activation. They must meet the bioenergetic and biosynthetic demands of increased cell proliferation and also adapt to changing environmental conditions, in which nutrients and oxygen may be limiting. An emerging theme in immunology is that metabolic reprogramming and lymphocyte activation are intricately linked. However, why T cells adopt specific metabolic programs and the impact that these programs have on T cell function and, ultimately, immunological outcome remain unclear. Research on tumor cell metabolism has provided valuable insight into metabolic pathways important for cell proliferation and the influence of metabolites themselves on signal transduction and epigenetic programming. In this Review, we highlight emerging concepts regarding metabolic reprogramming in proliferating cells and discuss their potential impact on T cell fate and function.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/Bak-dependent mitochondrial outer membrane permeabilization.

              Mitochondrial fusion and division play important roles in the regulation of apoptosis. Mitochondrial fusion proteins attenuate apoptosis by inhibiting release of cytochrome c from mitochondria, in part by controlling cristae structures. Mitochondrial division promotes apoptosis by an unknown mechanism. We addressed how division proteins regulate apoptosis using inhibitors of mitochondrial division identified in a chemical screen. The most efficacious inhibitor, mdivi-1 (for mitochondrial division inhibitor) attenuates mitochondrial division in yeast and mammalian cells by selectively inhibiting the mitochondrial division dynamin. In cells, mdivi-1 retards apoptosis by inhibiting mitochondrial outer membrane permeabilization. In vitro, mdivi-1 potently blocks Bid-activated Bax/Bak-dependent cytochrome c release from mitochondria. These data indicate the mitochondrial division dynamin directly regulates mitochondrial outer membrane permeabilization independent of Drp1-mediated division. Our findings raise the interesting possibility that mdivi-1 represents a class of therapeutics for stroke, myocardial infarction, and neurodegenerative diseases.
                Bookmark

                Author and article information

                Contributors
                URI : https://loop.frontiersin.org/people/2232617Role: Role: Role: Role: Role: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2397470Role: Role: Role:
                Role: Role: Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/112396Role:
                Role: Role: Role:
                URI : https://loop.frontiersin.org/people/2604848Role: Role:
                URI : https://loop.frontiersin.org/people/2398330Role:
                URI : https://loop.frontiersin.org/people/803456Role: Role: Role:
                URI : https://loop.frontiersin.org/people/132988Role: Role: Role: Role: Role: Role: Role: Role: Role: Role:
                URI : https://loop.frontiersin.org/people/679561Role: Role: Role: Role: Role:
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                15 January 2024
                2023
                : 14
                : 1270268
                Affiliations
                [1] 1 Institut Necker Enfant-Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris , Paris, France
                [2] 2 Platform for Image Analysis Center, SFR Necker, INSERM US 24 - CNRS UMS 3633 , Paris, France
                [3] 3 Platform for Cytometry, SFR Necker, INSERM US 24 - CNRS UMS 3633 , Paris, France
                [4] 4 Platform for Metabolic Analyses, SFR Necker, INSERM US 24 - CNRS UMS 3633 , Paris, France
                [5] 5 Mitochondrial Biology Group, Institut Pasteur, CNRS UMR 3691 , Paris, France
                Author notes

                Edited by: Ariel Quintana, Moffitt Cancer Center, United States

                Reviewed by: Namrata Gautam, Moffitt Cancer Center, United States

                Suyasha Roy, National Institutes of Health (NIH), United States

                *Correspondence: Rima Elhage, rima.elhage@ 123456inserm.fr

                †These authors have contributed equally to this work

                ‡These authors have contributed equally to this work and share last authorship

                Article
                10.3389/fimmu.2023.1270268
                10822881
                38288115
                6199aad7-aec8-4fdf-ba78-52fdffff7feb
                Copyright © 2024 Elhage, Kelly, Goudin, Megret, Legrand, Nemazanyy, Patitucci, Quellec, Wai, Hamaï and Ezine

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 31 July 2023
                : 20 December 2023
                Page count
                Figures: 6, Tables: 0, Equations: 0, References: 66, Pages: 17, Words: 9057
                Funding
                The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by core funding from the INSERM, CNRS, the University Paris Descartes and the Secular Society (TSS). AH was supported by grants from la ligue nationale contre le cancer and the Comité de Paris de la ligue contre le cancer.
                Categories
                Immunology
                Original Research
                Custom metadata
                T Cell Biology

                Immunology
                thymus,t cell progenitors,β-selection checkpoint,mitochondrial dynamics,metabolome,glycolysis,oxphos

                Comments

                Comment on this article